tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tejas Savant, 161 are a HOLD (47.77%), 14 are a SELL (4.15%), 162 are a BUY (48.07%).
Analyst Tejas Savant, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 47.24% that have a potential upside of 35.28% achieved within 171 days.
Tejas Savant’s has documented 671 price targets and ratings displayed on 37 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.
Most recent stock forecast was given on ADPT, Adaptive Biotechnologies Corp at 09-Jul-2026.
Analyst best performing recommendations are on CTKB (CYTEK BIOSCIENCES).
The best stock recommendation documented was for CTKB (CYTEK BIOSCIENCES) at 2/29/2024. The price target of $9 was fulfilled within 1 day with a profit of $1.3 (16.88%) receiving and performance score of 168.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Sep-2020
$20
$-1.06 (-5.03%)
$18
7 days ago
(09-Jul-2026)
12/17 (70.59%)
$-1.8 (-8.26%)
517
Buy Since 30-Sep-2025
$22
$0.94 (4.46%)
$21
17 days ago
(29-Jun-2026)
4/4 (100%)
$0.6 (2.80%)
67
Buy Since 07-Oct-2020
$22
$1.04 (4.96%)
$22
29 days ago
(17-Jun-2026)
12/19 (63.16%)
$5.22 (31.11%)
231
Buy Since 03-Aug-2023
$20
$-0.96 (-4.58%)
$10
8 months 10 days ago
(06-Nov-2025)
8/8 (100%)
$4.44 (28.53%)
204
Buy Since 21-Dec-2022
$20
$-0.96 (-4.58%)
$15
9 months 1 days ago
(15-Oct-2025)
14/14 (100%)
$2.89 (16.89%)
332
Which stock is Tejas Savant is most bullish on?
Which stock is Tejas Savant is most reserved on?
What Year was the first public recommendation made by Tejas Savant?
